Tower Research Capital (TRC)’s Anixa Biosciences ANIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,799
| Closed | -$4.17K | – | 5163 |
|
|
2024
Q4 | $4.17K | Buy |
1,799
+316
| +21% | +$981 | ﹤0.01% | 4501 |
|
|
2024
Q3 | $4.67K | Sell |
1,483
-4,896
| -77% | -$15.1K | ﹤0.01% | 4457 |
|
|
2024
Q2 | $14.1K | Buy |
6,379
+844
| +15% | +$2.39K | ﹤0.01% | 3964 |
|
|
2024
Q1 | $17.3K | Buy |
5,535
+2,832
| +105% | +$11.3K | ﹤0.01% | 3128 |
|
|
2023
Q4 | $10.5K | Sell |
2,703
-13,060
| -83% | -$44K | ﹤0.01% | 4239 |
|
|
2023
Q3 | $51.5K | Buy |
15,763
+12,596
| +398% | +$44.1K | ﹤0.01% | 2529 |
|
|
2023
Q2 | $10.1K | Sell |
3,167
-226
| -7% | -$871 | ﹤0.01% | 4156 |
|
|
2023
Q1 | $14K | Buy |
3,393
+3,190
| +1,571% | +$14K | ﹤0.01% | 3861 |
|
|
2022
Q4 | $1K | Buy |
+203
| New | +$976 | ﹤0.01% | 5542 |
|
|
2022
Q3 | – | Sell |
-1,452
| Closed | -$4K | – | 6030 |
|
|
2022
Q2 | $4K | Sell |
1,452
-4,531
| -76% | -$14.3K | ﹤0.01% | 5162 |
|
|
2022
Q1 | $16K | Buy |
5,983
+3,060
| +105% | +$8.98K | ﹤0.01% | 3740 |
|
|
2021
Q4 | $9K | Sell |
2,923
-412
| -12% | -$1.67K | ﹤0.01% | 4670 |
|
|
2021
Q3 | $16K | Sell |
3,335
-16,644
| -83% | -$75.1K | ﹤0.01% | 3910 |
|
|
2021
Q2 | $77K | Buy |
+19,979
| New | +$85.1K | ﹤0.01% | 2634 |
|
|
2021
Q1 | – | Sell |
-14,218
| Closed | -$44K | – | 5367 |
|
|
2020
Q4 | $44K | Buy |
14,218
+10,308
| +264% | +$25.9K | ﹤0.01% | 3225 |
|
|
2020
Q3 | $10K | Sell |
3,910
-2,582
| -40% | -$6.66K | ﹤0.01% | 4087 |
|
|
2020
Q2 | $20K | Buy |
6,492
+1,330
| +26% | +$2.76K | ﹤0.01% | 3668 |
|
|
2020
Q1 | $8K | Sell |
5,162
-955
| -16% | -$2.8K | ﹤0.01% | 2103 |
|
|
2019
Q4 | $20K | Buy |
6,117
+5,210
| +574% | +$19.1K | ﹤0.01% | 1906 |
|
|
2019
Q3 | $4K | Buy |
907
+698
| +334% | +$2.92K | ﹤0.01% | 3382 |
|
|
2019
Q2 | $1K | Sell |
209
-790
| -79% | -$3.34K | ﹤0.01% | 3401 |
|
|
2019
Q1 | $5K | Sell |
999
-373
| -27% | -$1.78K | ﹤0.01% | 3036 |
|
|
2018
Q4 | $5K | Buy |
1,372
+253
| +23% | +$1.09K | ﹤0.01% | 2876 |
|
|
2018
Q3 | $5K | Sell |
1,119
-1,547
| -58% | -$5.83K | ﹤0.01% | 3095 |
|
|
2018
Q2 | $8K | Buy |
+2,666
| New | +$9.88K | ﹤0.01% | 2865 |
|
|
2016
Q4 | – | Sell |
-800
| Closed | -$3K | – | 3790 |
|
|
2016
Q3 | $3K | Sell |
800
-177
| -18% | -$590 | ﹤0.01% | 2809 |
|
|
2016
Q2 | $3K | Buy |
977
+160
| +20% | +$487 | ﹤0.01% | 3652 |
|
|
2016
Q1 | $2K | Buy |
817
+718
| +725% | +$2.06K | ﹤0.01% | 3316 |
|
|
2015
Q4 | $0 | Sell |
99
-861
| -90% | -$3.02K | ﹤0.01% | 4430 |
|
|
2015
Q3 | $5K | Buy |
+960
| New | +$4.46K | ﹤0.01% | 2766 |
|
Other funds holding ANIX
LNWTC
DADC
MWM
Tower Research Capital (TRC)'s ANIX Position: Q1 2025 in Review
Tower Research Capital (TRC) sold out of Anixa Biosciences (ANIX) in Q1 2025, closing a stake of 1,799 shares — an estimated $4.17K sold.
Tower Research Capital (TRC) first reported a position in ANIX in Q3 2015 and held it in 30 quarters. The position peaked at $77K in Q2 2021. 58 funds tracked by Wall St. Rank hold ANIX as of Q1 2025.
- Tower Research Capital (TRC) reported no remaining Anixa Biosciences position as of Q1 2025 after selling out during the quarter.
- Tower Research Capital (TRC) sold 1,799 Anixa Biosciences shares in Q1 2025, an estimated $4.17K.
- Tower Research Capital (TRC) first reported a position in Anixa Biosciences in Q3 2015 and held it in 30 quarters.
- Tower Research Capital (TRC)'s Anixa Biosciences position peaked at $77K in Q2 2021.
- 58 funds tracked by Wall St. Rank held Anixa Biosciences as of Q1 2025.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.